Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

NCT01428661 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

507

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: tasimelteon
DRUG: placebo

Sponsor

Vanda Pharmaceuticals